Antithesis Ventures Fund I LP

New Filing
CIK: 0002126448·Pooled Investment Fund·DELAWARE·Filed: Apr 3, 2026
Total Offering

$20,000,000

Amount Sold

$0

Investors

0

First Sale

N/A

Offering Details

Type
Equity, Pooled Investment Fund
Exemptions
Rule 506(c), Section 3(c), Section 3(c)(1)
Entity Type
Limited Partnership
Year Incorporated
2026
Non-Accredited Investors
No

Related Persons

NameRole
N/A Antithesis Ventures Fund I GP LLC
Alexander Shtarkman

Company

Antithesis Ventures Fund I LP

1319 F. ST NW, STE. 301

WASHINGTON, DC, DC, 20004

202-431-3545

SEC Filing

0002126448-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Antithesis Ventures Fund I LP Form D Filing — $20,000,000 | FilingFlow